Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen Dosing in Childhood-onset GHD Transition (CATS)
NCT00109733Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Jan 2005
- Primary completion
- Jun 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by EMD Serono. Started Jan 2005; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00109733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109733.